This article was originally published in The Gray Sheet
Comments are due to the agency by Jan. 6, 2000 on recently released draft guidance on premarket approval applications for assays for diagnosis or monitoring of hepatitis C that would allow use of unapproved HCV-RNA assays as corroborating evidence, as long as supporting information is provided
You may also be interested in...
Positive test results with Abbott's AxSYM hepatitis C virus (HCV) microparticle enzyme immunoassay (MEIA) should be verified with a specific or supplemental test before being reported to the patient, FDA's Microbiology Devices Panel recommended at its Jan. 21 meeting in Rockville, Maryland.
The maker of prestige-inspired cosmetics at value prices follows its TikTok viral success by teaming with Kathleen Belsten, aka Loserfruit, the second most-followed female gamer on the Amazon-owned livestreaming platform Twitch.